On August 9th, 2021, Shengda received the Biotin CEP/COS certificate issued by European Directorate for the Quality of Medicines& HealthCare(EDQM), which marked Shengda as the first biotin drug manufacturer in China to have the certificate.

     For a long time, the Biotin produced by domestic manufacturers is mainly used for feed, food and health care products, and the vast majority of pharmaceutical Biotin supply in the world has been monopolized by foreign giants. The harvest of this certificate marks Shengda’s official entry into the national regulations pharmaceutical market, which is conducive to the products moving towards the high-end level and helping the development of China's national pharmaceutical industry.